Biocon planning new biomanufacturing plant in India
Indian drugmaker and biosimilars pioneer Biocon has told the Chief Minister of Andhra Pradesh it intends to set up a new biomanufacturing plant.
Archives for December 17, 2014
Immunotherapy in the UK? National manufacturing site backed by GE
GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.
Rouble trouble: Big Pharma exposure to Russian currency volatility limited
Big Pharma firms’ exposure to Russia’s volatile rouble is limited and planned manufacturing investments will go ahead according to observers.